HRSA Issues Proposed 340B Drug Pricing Program “Mega Guidance”

This week, our In Focus section comes to us from HMA Managing Principal Donna Strugar-Fritsch and Research Assistant Melissa Sanchez. Donna and Melissa provide a review of the proposed guidance issued by the Health Resources and Services Administration (HRSA) on the 340B Drug Pricing Program.

Every Wednesday, HMA publishes the Weekly Roundup, an information-packed resource that will keep you updated on industry news, trends in state health policy throughout the nation, and more.